Sanofi

Phone: +33153774000

Web: https://www.sanofi.com

Formerly	Sanofi-Synthélabo (1999–2004) Sanofi-Aventis (2004–2011)
Type	Société Anonyme
Traded as	Euronext Paris: SAN Nasdaq: SNY CAC 40 Component
ISIN
Industry	Pharmaceuticals
Founded	1973 (1973)
Headquarters	54 Rue La Boétie Paris, France 75008
Area served	Worldwide
Key people	Serge Weinberg (Chairman) Paul Hudson (CEO)
Products	Pharmaceuticals, generic drugs, over-the-counter drugs, vaccines, diagnostics, contact lenses, animal health (list...)
Revenue	€36.12 billion (2020)
Operating income	€15.50 billion (2020)
Net income	€12.35 billion (2020)
Total assets	€115.75 billion (2020)
Total equity	€60.10 billion (2020)
Number of employees	99,412 (2020)
Subsidiaries	Sanofi Pasteur Genzyme Shantha Biotechnics Chattem Ablynx Bioverativ
Website	www.sanofi.com

Sanofi is a global biopharmaceutical company focused on human health. Sanofi engages in the research and development, manufacturing and marketing of pharmaceutical drugs principally in the prescription market, but the firm also develops over-the-counter medication. The company covers seven major therapeutic areas: cardiovascular, central nervous system, diabetes, internal medicine, oncology, thrombosis and vaccines (it is the world's largest producer of the latter through its subsidiary Sanofi Pasteur).

For detailed contact information visit location pages below.